July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 19, 2025

Plaque Calcification May Predict Future Hemorrhage Risk

New research tracked subclinical carotid plaque changes over six years and found that plaques with calcification were twice as likely to develop intraplaque hemorrhage, with men showing greater risk for complex plaque progression.

Conexiant

November 14, 2024

AI-Powered Camera Detects Hypertension, Diabetes

An AI-powered high-speed video camera offers quick, no-contact screenings for high blood pressure and diabetes by analyzing blood flow features in face and palm skin, achieving impressive accuracies.

Reuters

January 09, 2025

Study: Aspirin Shields SLE Patients from ASCVD

A recent study has linked antiphospholipid antibodies to atherosclerotic cardiovascular disease in systemic lupus erythematosus patients, highlighting the potential of aspirin to reduce risk. Source: BMC Medicine

Conexiant

April 30, 2025

ApoB Count and Lp(a) Levels Key to CAD Risk

Total apoB particle count and Lp(a) levels best reflect coronary artery disease risk, with researchers noting that lipid-related atherosclerotic risk is most accurately reflected by the total count of apoB-P.

Conexiant

May 30, 2025

Mepolizumab Reduces COPD Flares in Eosinophilic Patients

A new clinical trial found that adding mepolizumab to standard inhaled therapy significantly reduced moderate or severe COPD exacerbations in patients with high eosinophil counts, with a 21% lower annual rate and longer time to first flare.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant